UTHR - UNITED THERAPEUTICS Corp

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 433.34

Open

$ 432.23

Bid

$ 425.00 x 13

Ask

$ 442.00 x 200

Day's Range

$ 428.04 - $ 435.38

52 Week Range

$ 266.98 - $ 459.48

Volume

524,679

Average Volume

Market Cap

19.6B

Beta (5Y Monthly)

$ 0.51

PE Ratio (TTM)

$ 15.78

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-30-2025	06-30-2025	10-Q
2	04-30-2025	03-31-2025	10-Q
3	02-26-2025	12-31-2024	10-K
4	10-30-2024	09-30-2024	10-Q
5	07-31-2024	06-30-2024	10-Q
6	05-01-2024	03-31-2024	10-Q
7	02-21-2024	12-31-2023	10-K
8	11-01-2023	09-30-2023	10-Q
9	08-02-2023	06-30-2023	10-Q
10	05-03-2023	03-31-2023	10-Q
11	02-22-2023	12-31-2022	10-K
12	11-02-2022	09-30-2022	10-Q
13	08-03-2022	06-30-2022	10-Q
14	05-04-2022	03-31-2022	10-Q
15	02-24-2022	12-31-2021	10-K
16	11-03-2021	09-30-2021	10-Q
17	08-04-2021	06-30-2021	10-Q
18	05-05-2021	03-31-2021	10-Q
19	02-24-2021	12-31-2020	10-K
20	10-28-2020	09-30-2020	10-Q
21	07-29-2020	06-30-2020	10-Q
22	04-29-2020	03-31-2020	10-Q
23	02-26-2020	12-31-2019	10-K
24	10-30-2019	09-30-2019	10-Q
25	07-31-2019	06-30-2019	10-Q
26	05-01-2019	03-31-2019	10-Q
27	02-27-2019	12-31-2018	10-K
28	10-31-2018	09-30-2018	10-Q
29	08-01-2018	06-30-2018	10-Q
30	05-02-2018	03-31-2018	10-Q
31	02-21-2018	12-31-2017	10-K
32	10-25-2017	09-30-2017	10-Q
33	07-27-2017	06-30-2017	10-Q
34	04-26-2017	03-31-2017	10-Q
35	02-22-2017	12-31-2016	10-K
36	10-27-2016	09-30-2016	10-Q
37	07-28-2016	06-30-2016	10-Q
38	04-28-2016	03-31-2016	10-Q
39	02-25-2016	12-31-2015	10-K
40	10-27-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

United Therapeutics to Present Latest Pulm...
10/13/2025 11:07:41

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced two presentations at the upcoming...

Morgan Stanley Maintains Equal-Weight on U...
10/10/2025 17:26:58

Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price ta...

UBS Maintains Buy on United Therapeutics, ...
09/29/2025 13:42:15

UBS analyst Ashwani Verma maintains United Therapeutics (NASDAQ: UTHR) with a Buy and raises the price target from $560 to $...

this-united-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday

This United Therapeutics Analyst Begins Co...
09/26/2025 12:03:22

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

RBC Capital Initiates Coverage On United T...
09/26/2025 11:41:21

RBC Capital analyst Lisa Walter initiates coverage on United Therapeutics (NASDAQ: UTHR) with a Outperform rating and announ...

United Therapeutics To Review Positive TET...
09/19/2025 11:03:15

United Therapeutics To Showcase New Lung D...
09/12/2025 11:03:13

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its c...

Cantor Fitzgerald Maintains Overweight on ...
09/10/2025 13:04:57

Cantor Fitzgerald analyst Olivia Brayer maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price t...

wayfair-united-therapeutics-and-ciena-are-among-the-top-10-large-cap-gainers-last-week-sep-1-sep5-are-the-others-in-your-portfolio-corrected

Wayfair, United Therapeutics, And Ciena Ar...
09/07/2025 14:30:00

These ten large-cap stocks were top performers last week. Are they a part of your portfolio?

Oppenheimer Maintains Outperform on United...
09/05/2025 14:34:58

Oppenheimer analyst Andreas Argyrides maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price tar...

HC Wainwright & Co. Maintains Buy on Unite...
09/05/2025 11:47:12

HC Wainwright & Co. analyst Andrew Fein maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price targ...

UBS Maintains Buy on United Therapeutics, ...
09/04/2025 12:41:14

UBS analyst Ashwani Verma maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $415 to $560.

Wells Fargo Maintains Equal-Weight on Unit...
09/03/2025 13:02:16

Wells Fargo analyst Tiago Fauth maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price target ...

Jefferies Maintains Buy on United Therapeu...
09/02/2025 18:26:45

Jefferies analyst Roger Song maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $432 to...

B of A Securities Maintains Neutral on Uni...
09/02/2025 17:46:33

B of A Securities analyst Greg Harrison maintains United Therapeutics (NASDAQ:UTHR) with a Neutral and raises the price targ...

12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 17:06:49

dow-tumbles-over-1-nio-shares-edge-lower-after-q2-results

Dow Tumbles Over 1%; Nio Shares Edge Lower...
09/02/2025 16:55:35

why-is-united-therapeutics-stock-rallying-on-tuesday

Why Is United Therapeutics Stock Rallying ...
09/02/2025 14:59:49

United Therapeutics' Tyvaso showed significant lung function improvement in IPF patients, with plans to seek FDA approval f...

air-lease-ionis-pharmaceuticals-arrowhead-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday

Air Lease, Ionis Pharmaceuticals, Arrowhea...
09/02/2025 14:41:45

12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 12:08:23